Bulletin
Investor Alert

Jan. 20, 2020, 7:49 a.m. EST

Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Transcanna Holdings Inc. (TCNAF)
  • X
    Transcanna Holdings Inc. (TH8)
  • X
    Canopy Growth Corp. (WEED)

or Cancel Already have a watchlist? Log In

By Benzinga.com

Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 marijuana stock news stories for the week of January 13th – 19th, 2020.

Without further ado, let’s get started.

These Pot Stocks Received BUY Ratings and Bullish Price Targets Up to 185% Above Market

After 2019’s market shakeout, analysts say the right U.S. and Canadian Cannabis Stocks will rise in 2020. These Pot Stocks could deliver major gains by taking advantage of their financial position and competitive edge in 2020.

READ FULL CANNABIS COMEBACK ARTICLE

TCAN Stock is Forming a Bullish Chart Pattern with the Potential for Another Large Breakout

TransCanna Holdings (cse:TCAN) /zigman2/quotes/208120352/delayed TCNAF 0.00% /zigman2/quotes/208531824/delayed DE:TH8 +0.57%  announced that its December revenue grew 20% month over month with net income from operations accounting for 16%. TCAN stock has been on a tear over the past 2.5 months soaring as much as 436%. The stock has recently pulled back and could be setting up for another large move to the upside.

READ FULL TRANSCANNA ARTICLE

Rumours Are Swirling That MMEN is Reaching Out to Debtholders to Negotiate Restructuring the Company

Medmen Enterprises (cse:MMEN) (otcqx:MMNNF) (fra:0JS) is rumoured to be offering $0.50 on the dollar to owners of MedMen debt and telling certain service providers that they aren’t able to pay outstanding bills.

READ FULL MEDMEN ARTICLE

CGC Says Scaling Process is Not Complete, Delays Beverage Launch

Canopy Growth /zigman2/quotes/202205609/delayed CA:WEED +2.81% /zigman2/quotes/200603886/composite CGC +2.48% (fra:11L1) management remains very confident in the underlying beverage science and in its ability to scale production and deliver high quality, differentiated cannabis beverages to the market. However, the scaling process is not complete, and the company is extending its to-market date while the internal teams complete the final steps.

READ FULL CANOPY GROWTH ARTICLE

Adjusted EBITDA Soars 155% + APHA Stock Chart Review

Aphria /zigman2/quotes/205566616/delayed CA:APHA +1.07% /zigman2/quotes/207425803/composite APHA +0.71% (fra:10E) announced earnings for the second quarter ended November 30, 2019, with the company recording its third straight quarter of positive adjusted EBITDA. The company also lowered its fiscal 2020 earnings forecast.

/zigman2/quotes/208120352/delayed
US : U.S.: OTC
$ 0.70
0.00 0.00%
Volume: 11,225
Feb. 20, 2020 1:11p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
N/A
Rev. per Employee
N/A
loading...
/zigman2/quotes/208531824/delayed
DE : Germany: Frankfurt
0.70
+0.0040 +0.57%
Volume: 13,352
Feb. 20, 2020 8:59p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
N/A
Rev. per Employee
N/A
loading...
/zigman2/quotes/202205609/delayed
CA : Canada: Toronto
$ 29.59
+0.81 +2.81%
Volume: 3.63M
Feb. 20, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$10.03 billion
Rev. per Employee
$150,142
loading...
/zigman2/quotes/200603886/composite
US : U.S.: NYSE
$ 22.31
+0.54 +2.48%
Volume: 8.83M
Feb. 20, 2020 6:30p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$7.59 billion
Rev. per Employee
$115,039
loading...
/zigman2/quotes/205566616/delayed
CA : Canada: Toronto
$ 5.66
+0.06 +1.07%
Volume: 2.80M
Feb. 20, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$1.42 billion
Rev. per Employee
$190,843
loading...
/zigman2/quotes/207425803/composite
US : U.S.: NYSE
$ 4.26
+0.03 +0.71%
Volume: 5.91M
Feb. 20, 2020 6:30p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$1.07 billion
Rev. per Employee
$147,410
loading...
1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.